ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 977,76
0,06%
Dow Jones
44 470,41
0,38%
DAX
21 911,74
0,68%
Brent Oil
75,785
-0,18%
Bitcoin
98 010,11
0,54%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Hemostemix Inc (QB) (HMTXF) Cours

Hemostemix Inc (QB)

Hemostemix Inc (QB) (HMTXF)

USOTC
0,1864
0,0039
(2,14%)
Fermé 11 Février 10:00PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,1864
Prix Achat
0,0001
Prix Vente
1 200,29
Volume échangé
17 800
0,1859 Fourchette du Jour 0,1899
0,024 Plage de 52 semaines 0,285
Cap du marché
26,402M
Clôture Veille
0,1825
Ouverture
0,1859
Dernière Transaction
8200
@
0.1864
Dernière heure de transaction
Volume financier
US$ 3 345
VWAP
0,187894
Volume moyen (3 m)
58 431
Actions en circulation
141 641 969
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,69
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
200k
Bénéfice net
-2,5M

À propos de Hemostemix Inc (QB)

Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). Show more

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Site Web
www.hemostemix.com
Siège social
Calgary, Alberta, Can
Fondé
2014
Hemostemix Inc (QB) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker HMTXF. Le dernier cours de clôture d'Hemostemix (QB) était de US$0,18. Au cours de la dernière année, les actions de Hemostemix (QB) ont été négociées dans une fourchette de prix de US$ 0,024 à US$ 0,285.

Hemostemix (QB) compte actuellement 141 641 969 actions en circulation. La capitalisation boursière d'Hemostemix (QB) est de US$25,85 million. Hemostemix (QB) a un ratio cours/bénéfice (ratio PE) de -14.69.

HMTXF Dernières nouvelles

Plus de nouvelles

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

  HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT     May 10, 2021, Calgary, Alberta -- InvestorsHub NewsWire -- Hemostemix Inc...

11 Mai 2021
InvestorsHub NewsWire

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

 Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list  Calgary, Alberta, April 23, 2021-- InvestorsHub NewsWire -- Hemostemix Inc. ("Hemostemix" or the...

26 Avril 2021
InvestorsHub NewsWire

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

  Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and  Litigation Updates   Calgary, Alberta, April 12, 2021-- InvestorsHub NewHemostemix Inc...

12 Avril 2021
InvestorsHub NewsWire

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

Hemostemix Annonces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets LTD.   Calgary, Alberta, April 8, 2021 -- InvestorsHub NewsWire...

09 Avril 2021
InvestorsHub NewsWire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0136-6.80.20.210.1825436990.1989109CS
40.022914.0061162080.16350.2850.14928430.22614879CS
120.1315239.5264116580.05490.2850.0438584310.20770277CS
260.1496406.521739130.03680.2850.0301448490.15732807CS
520.1252204.5751633990.06120.2850.024319950.13805826CS
1560.068758.36873406970.11770.32790.024250610.15128262CS
2600.18153704.081632650.00490.43720.0049363060.09477681CS

HMTXF - Frequently Asked Questions (FAQ)

What is the current Hemostemix (QB) share price?
The current share price of Hemostemix (QB) is US$ 0,1864
How many Hemostemix (QB) shares are in issue?
Hemostemix (QB) has 141 641 969 shares in issue
What is the market cap of Hemostemix (QB)?
The market capitalisation of Hemostemix (QB) is USD 25,85M
What is the 1 year trading range for Hemostemix (QB) share price?
Hemostemix (QB) has traded in the range of US$ 0,024 to US$ 0,285 during the past year
What is the PE ratio of Hemostemix (QB)?
The price to earnings ratio of Hemostemix (QB) is -14,69
What is the cash to sales ratio of Hemostemix (QB)?
The cash to sales ratio of Hemostemix (QB) is 185,71
What is the reporting currency for Hemostemix (QB)?
Hemostemix (QB) reports financial results in CAD
What is the latest annual turnover for Hemostemix (QB)?
The latest annual turnover of Hemostemix (QB) is CAD 200k
What is the latest annual profit for Hemostemix (QB)?
The latest annual profit of Hemostemix (QB) is CAD -2,5M
What is the registered address of Hemostemix (QB)?
The registered address for Hemostemix (QB) is SUITE 1150, 707-7TH AVE SW, CALGARY, CALGARY, ALBERTA, T2P 3H6
What is the Hemostemix (QB) website address?
The website address for Hemostemix (QB) is www.hemostemix.com
Which industry sector does Hemostemix (QB) operate in?
Hemostemix (QB) operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NHHSNorthStar Healthcare Income Inc (PK)
US$ 1,00
(333 233,33%)
733
MJNEMJ Holdings Inc (CE)
US$ 0,0003
(29 900,00%)
80,55k
TTCMTautachrome Inc (CE)
US$ 0,0002
(19 900,00%)
1,48M
BRGOBergio International Inc (PK)
US$ 0,0001
(9 900,00%)
1,5M
TTCFQTattooed Chef Inc (CE)
US$ 0,0001
(9 900,00%)
47,19k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,000001
(-99,99%)
519
AGLYAtlantis Glory Inc (PK)
US$ 0,0018
(-99,91%)
2,5k
OGAAOrganic Agricultural Company Ltd (CE)
US$ 0,000001
(-99,80%)
6,2k
IVRNInnoveren Scientific Inc (CE)
US$ 0,000001
(-99,80%)
600
ELYSElys BMG Group Inc (CE)
US$ 0,000001
(-99,75%)
3,62k
HMBLHUMBL Inc (PK)
US$ 0,0005
(0,00%)
318,98M
ENDVEndonovo Therapeutics Inc (PK)
US$ 0,00025
(0,00%)
145,73M
VTXBVortex Brands Company (PK)
US$ 0,0001
(0,00%)
130,18M
SPQSSportsQuest Inc (PK)
US$ 0,0004
(0,00%)
130,05M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,0001
(0,00%)
125,13M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
HMTXF
Hemostemix (QB)
BIT
I09756
XS2720885354 20251229 0....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces